The team applied this method to mRNA/saRNA constructs from 1 to 10 kb and assessed pH ranges from 3 to 6. For all the RNA constructs, the J2 immunoblot signal—a marker for dsRNA strands—decreased with ...
COVID-19 vaccine stock Moderna just got its biggest lift in recent memory, moving up 17%. Can MRNA stage a broader recovery, ...
Despite Sanofi CEO Paul Hudson’s confidence in vaccines, the French pharma has cut at least one mRNA flu shot program.
UpGuard, a leader in cybersecurity and risk management, released new research highlighting a critical security vulnerability within developer workflows. UpGuard's analysis of more than 18,000 AI agent ...
GlobalData on MSN
Moderna’s cancer vaccine plus Keytruda boosts RFS in melanoma study
A combination of intismeran autogene and Keytruda significantly prolonged recurrence-free survival in melanoma.
A new study shows lipid nanoparticles can be formulated at much higher lipid concentrations using a modular mixing approach, ...
Hologic, Inc. announced today that its Aptima® HPV Assay received FDA approval for clinician-collected HPV primary screening. Hologic's human papillomavirus (HPV) test is the only FDA-approved ...
Moderna, Inc. vs. Novavax, Inc.: cost cuts, vaccine pipeline catalysts, and valuations. Click for this comparison of NVAX and ...
New York Magazine on MSNOpinion
The New Politics of the AI Apocalypse
Dario Amodei, CEO of Anthropic, says more democracy is the best response to AI. He doesn’t sound too confident.
By adding AI-enabled RNA design and active learning, Eclipsebio extends its sequencing-based analytics platform into a fully ...
The global vaccine Contract Development and Manufacturing Organization (CDMO) market is projected to expand at a compound ...
GlobalData on MSN
Genespire to take rare disease gene therapy to clinic in 2026
GENE202 is a single dose gene therapy for patients with rare metabolic disease, methylmalonic acidaemia.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results